4/14/2020 8:28:09 PM
Our Commitment to Beat Coronavirus
In these unprecedented times, we are coming together to achieve one shared goal: to beat COVID-19. The decades-long investments we have made in new technology, research and treatments have prepared us to act swiftly:
In Common: See How the Biopharmaceutical Industry Is Working to Defeat a Common Threat: COVID–19>
As the fight to research and develop innovative treatments and vaccines advances, three biopharmaceutical scientists share what they have in common: combatting COVID-19.
Doing Our Part to Fight Coronavirus>
Just as you are doing your part to fight the novel coronavirus, America's Biopharmaceutical Companies are working around the clock to fight COVID-19.
Video: Biopharmaceutical Innovation Fighting COVID-19>
America's biopharmaceutical companies are working together to end the COVID-19 pandemic. Watch here to see the five big ways they are tackling the virus right now.
The Biopharmaceutical Industry is Leading the Way in Developing New Vaccines and Treatments for COVID-19>
America’s biopharmaceutical companies are committed to developing solutions to help diagnose, treat and prevent COVID-19, a disease caused by a novel strain of coronavirus.
PhRMA COVID-19 Activity Tracker>
America’s biopharmaceutical companies are coming together to achieve one common goal: to beat COVID-19. Browse and discover the data behind the historic effort PhRMA Members are undertaking to treat and defend against the disease caused by the novel coronavirus.
PhRMA @ Home>
Click or tap for a collection of video sessions with experts from PhRMA commenting on various aspects of ongoing PhRMA member company efforts to support the detection, prevention and treatment of the coronavirus outbreak.
COVID-19: Glossary of Terms>
A glossary of common terms pertaining to COVID-19 therapeutics and vaccines.
Working Together to Fight COVID-19>
America’s biopharmaceutical companies have joined forces to fight COVID-19.
PhRMA Open Letter: To the Millions Affected by COVID-19>
In these unprecedented times, it can be hard to feel optimistic, but there are reasons to stay positive.
Industry Commitment to Combating Coronavirus Print Ad>
In these unprecedented times, America’s biopharmaceutical companies are coming together to achieve one shared goal: the eradication of COVID-19. The decades-long investments we made in new technology, research and treatments have prepared us to act swiftly.
Impact of Industry Sponsored Clinical Trials>
The biopharmaceutical industry brings profound value to patients through new treatments and cures for society’s most devastating and costly diseases and conditions, providing millions of patients with treatment options they would not otherwise have.